When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Thymectomy - Wikipedia

   en.wikipedia.org/wiki/Thymectomy

   D013934. [edit on Wikidata] A thymectomy is an operation to remove the thymus. It usually results in remission of myasthenia gravis with the help of medication including steroids. However, this remission may not be permanent. Thymectomy is indicated when thymoma are present in the thymus. Anecdotal evidence suggests MG patients with no evidence ...

3. Amgen's muscular disorder drug meets main goal in late-stage ...

   www.aol.com/news/amgens-muscular-disorder-drug...

   The company is testing its drug, inebilizumab or Uplizna, in patients suffering from myasthenia gravis, which is caused by an abnormal immune reaction that weakens the muscles that control the ...

4. Myasthenia gravis - Wikipedia

   en.wikipedia.org/wiki/Myasthenia_gravis

   Myasthenia gravis (MG) is a long-term neuromuscular junction disease that leads to varying degrees of skeletal muscle weakness. [1] The most commonly affected muscles are those of the eyes, face, and swallowing. [1][5] It can result in double vision, drooping eyelids, and difficulties in talking and walking. [1]

5. Efgartigimod alfa - Wikipedia

   en.wikipedia.org/wiki/Efgartigimod_alfa

   C2310H3554N602O692S14. Molar mass. 51 280.20 g·mol −1. Efgartigimod alfa, sold under the brand name Vyvgart, is a medication used to treat myasthenia gravis. [3][4] Efgartigimod alfa is a neonatal Fc receptor blocker and is a new class of medication. [4] It is an antibody fragment that binds to the neonatal Fc receptor (FcRn), preventing ...

6. Lambert–Eaton myasthenic syndrome - Wikipedia

   en.wikipedia.org/wiki/Lambert–Eaton_myasthenic...

   Myasthenia gravis is caused by autoantibodies to the postsynaptic acetylcholine receptors. Lambert–Eaton myasthenic syndrome (LEMS) is a rare autoimmune disorder characterized by muscle weakness of the limbs. It is also known as myasthenic syndrome, Eaton–Lambert syndrome, and when related to cancer, carcinomatous myopathy.

7. Mary Broadfoot Walker - Wikipedia

   en.wikipedia.org/wiki/Mary_Broadfoot_Walker

   Awards. Royal College of Physicians Jean Hunter Prize (1962) Mary Broadfoot Walker (17 April 1888 – 13 September 1974) was a Scottish physician who first demonstrated the effectiveness of physostigmine in the treatment of the condition myasthenia gravis, a disease relating to muscle weakness. She was also the first to recognise the ...